This inventor holds 1 USPTO granted patent. Top assignee: Spofa, Pharmaceutical Works. Active years: 1977.
Company Filing History:
Years Active: 1977
Title: Karel Rezabeck: Innovator in Pharmaceutical Chemistry
Introduction
Karel Rezabeck is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on derivatives of ergoline compounds. His research has led to advancements that may have important implications in medicinal chemistry.
Latest Patents
Karel Rezabeck holds 1 patent for his invention titled "N.beta.-substituted 8-.beta.-aminoethylergolin-I derivatives and their acid addition salts." This patent discloses novel N.beta.-substituted 8-.beta.-aminoethylergolin-I derivatives, which are prepared through either reductive alkylation or selective reduction of corresponding derivatives containing carbonyl groups. This work showcases his expertise in synthesizing complex chemical compounds.
Career Highlights
Karel Rezabeck is associated with Spofa, a well-known pharmaceutical company. His role at Spofa has allowed him to engage in cutting-edge research and development, contributing to the advancement of pharmaceutical products. His work is characterized by a commitment to innovation and excellence in the field.
Collaborations
Throughout his career, Karel has collaborated with esteemed colleagues such as Josef Kral and Miroslav Seda. These collaborations have fostered a productive environment for research and development, enhancing the impact of their collective work in the pharmaceutical industry.
Conclusion
Karel Rezabeck is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His innovative patents and collaborations reflect his dedication to advancing the field. His work continues to inspire future research and development in medicinal chemistry.